These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28323228)

  • 41. Synergistic antibacterial effect of silver and ebselen against multidrug-resistant Gram-negative bacterial infections.
    Zou L; Lu J; Wang J; Ren X; Zhang L; Gao Y; Rottenberg ME; Holmgren A
    EMBO Mol Med; 2017 Aug; 9(8):1165-1178. PubMed ID: 28606995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.
    Park SH; Choi SM; Chang YK; Lee DG; Cho SY; Lee HJ; Choi JH; Yoo JH
    J Antimicrob Chemother; 2014 Oct; 69(10):2848-56. PubMed ID: 24928854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; D' Angelo A; Fogari E; Maffioli P
    J Biol Regul Homeost Agents; 2013; 27(3):717-28. PubMed ID: 24152839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Silvestri C; Di Matteo F; Abbruzzetti A; Scalise G; Saba V
    Crit Care Med; 2008 Jan; 36(1):240-5. PubMed ID: 18090372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models.
    Szabo D; Ostorhazi E; Binas A; Rozgonyi F; Kocsis B; Cassone M; Wade JD; Nolte O; Otvos L
    Int J Antimicrob Agents; 2010 Apr; 35(4):357-61. PubMed ID: 20031377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
    Chang UI; Kim HW; Wie SH
    Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extract of Clinopodium bolivianum protects against E. coli invasion of uroepithelial cells.
    Mohanty S; Kamolvit W; Zambrana S; Sandström C; Gonzales E; Östenson CG; Brauner A
    J Ethnopharmacol; 2017 Feb; 198():214-220. PubMed ID: 28087472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.
    Jain V; Shukla P; Pal R; Mishra PR
    Pharm Res; 2014 Oct; 31(10):2630-42. PubMed ID: 24740243
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Mushtaq F; Akhtar MF; Saleem A; Sharif A; Akhtar B; Askary AE; Abdel-Daim MM; Javaid Z; Sohail K; Anwar F
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1390-1402. PubMed ID: 35579124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.
    Tan XX; Actor JK; Chen Y
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3203-7. PubMed ID: 16048926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; D'Amato G; Orlando F; Sisti V; Kamysz W; Silvestri C; Naldoski P; Lukasiak J; Saba V; Scalise G
    J Antimicrob Chemother; 2004 Sep; 54(3):654-60. PubMed ID: 15294887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Broad-spectrum beta-lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases.
    Vimont S; Aubert D; Mazoit JX; Poirel L; Nordmann P
    J Antimicrob Chemother; 2007 Nov; 60(5):1045-50. PubMed ID: 17804425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
    J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of liposomal antibiotic therapy in a rat infusion model of Escherichia coli peritonitis.
    Martineau L; Shek PN
    Crit Care Med; 1999 Jun; 27(6):1153-8. PubMed ID: 10397221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
    Luo Y; Luo R; Ding H; Ren X; Luo H; Zhang Y; Ye L; Cui S
    Microb Drug Resist; 2018 Mar; 24(2):175-180. PubMed ID: 28686503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phyto-chemical and pharmacological applications of Berberis aristata.
    Potdar D; Hirwani RR; Dhulap S
    Fitoterapia; 2012 Jul; 83(5):817-30. PubMed ID: 22808523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation.
    Krapp F; Grant JL; Sutton SH; Ozer EA; Barr VO
    Int J Antimicrob Agents; 2017 Jun; 49(6):770-773. PubMed ID: 28389354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic effect of ceftazidime in a rabbit model of peritonitis caused by Escherichia coli producing CTX-M-14 extended-spectrum beta-lactamase].
    Zhou JY; Xu PF; Chen H; Yu YS; Chen YG
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):689-93. PubMed ID: 16255954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
    Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
    Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.